Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma

Eyles, Jo, Puaux, Anne-Laure, Wang, Xiaojie, Toh, Benjamin, Prakash, Celine, Hong, Michelle, Tan, Tze Guan, Zheng, Lin +7 more·2010·Journal of Clinical Investigation
DOI 10.1172/jci42002

Cited by (505)

Items 201–300 of 505

  1. Metastasis: an early event in cancer progression
    Yijun Hu, Xiya Yu, Guixia Xu, Shanrong Liu · 2016 · Journal of Cancer Research and Clinical Oncology
  2. Dormancy in breast cancer
    Tanja Natascha Fehm, Banys, Hartkopf, Krawczyk, Meier-Stiegen, Hans J. Neubauer, Kaiser · 2012 · Breast Cancer Targets and Therapy
  3. IL4-induced gene 1 promotes tumor growth by shaping the immune microenvironment in melanoma
    Lloyd Bod, Renée Lengagne, Ludovic Jean Wrobel, Jan Philipp Ramspott, Masashi Kato, Marie‐Françoise Avril, Flavia Castellano, Valérie Molinier‐Frenkel, Armelle Prévost‐Blondel · 2017 · OncoImmunology
  4. Molecular Insights and Emerging Strategies for Treatment of Metastatic Uveal Melanoma
    Fabiana Mallone, Marta Sacchetti, Alessandro Lambìase, Antonietta Moramarco · 2020 · Cancers
  5. COVID-19–Induced Modifications in the Tumor Microenvironment: Do They Affect Cancer Reawakening and Metastatic Relapse?
    Federica Francescangeli, Maria Laura De Angelis, Marta Baiocchi, Rachele Rossi, Mauro Biffoni, Ann Zeuner · 2020 · Frontiers in Oncology
  6. The role of Snail1 transcription factor in colorectal cancer progression and metastasis
    Marlena Brzozowa-Zasada, Marek Michalski, Grzegorz Wyrobiec, Adam Piecuch, Anna Dittfeld, Marzena Harabin-Słowińska, Dariusz Boroń, Romuald Wojnicz · 2015 · Współczesna Onkologia
  7. Minimal Residual Disease, Metastasis and Immunity
    Jordi Badia-Ramentol, Jenniffer Linares, Andrea Gómez‐Llonín, Alexandre Calon · 2021 · Biomolecules
  8. Adjuvant therapy options in renal cell carcinoma — targeting the metastatic cascade
    Kelly N. Fitzgerald, Robert John Motzer, Chung‐Han Lee · 2022 · Nature Reviews Urology
  9. Immunogenic, cellular, and angiogenic drivers of tumor dormancy‐a melanoma view
    Daniela Senft, Ze’ev A. Ronai · 2015 · Pigment Cell & Melanoma Research
  10. Overexpression and potential targeting of the oncofoetal antigen 5T4 in malignant pleural mesothelioma
    Saly Al‐Taei, Josephine Salimu, Jason Francis Lester, Seamus J. Linnane, Madusha Goonewardena, Richard Harrop, Malcolm David Mason, Zsuzsanna Tabi · 2012 · Lung Cancer
  11. Animal Models of Uveal Melanoma: Methods, Applicability, and Limitations
    Marta M. Stei, Karin U. Loeffler, Frank Gerhard Holz, Martina C. Herwig‐Carl · 2016 · BioMed Research International
  12. Optimized magnitude of cryosurgery facilitating anti-tumor immunoreaction in a mouse model of Lewis lung cancer
    Yusuke Takahashi, Y. Izumi, N. Matsutani, H. Dejima, T. Nakayama, Ryo Okamura, H. Uehara, M. Kawamura · 2016 · Cancer Immunology and Immunotherapy
  13. The sleeping ugly: Tumour microenvironment's act to make or break the spell of dormancy
    Laurie J. Gay, Ilaria Malanchi · 2017 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  14. FBX8 promotes metastatic dormancy of colorectal cancer in liver
    Xiaohui Zhu, Feifei Wang, Xuehui Wu, Li Zhou, Zhizhi Wang, Xiaoli Ren, Yangshu Zhou, Fuyao Song, Yunshi Liang, Zhicheng Zeng et al. · 2020 · Cell Death and Disease
  15. Uveal melanoma dormancy
    Paula L. Blanco, Li Anne Lim, Cristina Miyamoto, Miguel N. Burnier · 2012 · Melanoma Research
  16. Insights into the role of senescence in tumor dormancy: mechanisms and applications
    Valerie J. DeLuca, Tareq Saleh · 2023 · Cancer and Metastasis Reviews
  17. Dacarbazine Promotes Stromal Remodeling and Lymphocyte Infiltration in Cutaneous Melanoma Lesions
    Alessandra Nardin, Wing‐Cheong Wong, Charlene Tow, Thierry Jo Molina, Frédérique Tissier, Anne Audebourg, Marylène Garcette, Anne Caignard, Marie‐Françoise Avril, Jean‐Pierre Abastado et al. · 2011 · Journal of Investigative Dermatology
  18. The Complexities of Metastasis
    Beatriz P. San Juan, María Jesús García-León, Laura Rangel, Jacky G. Goetz, Christine Louise Chaffer · 2019 · Cancers
  19. Thorny ground, rocky soil: Tissue-specific mechanisms of tumor dormancy and relapse
    Andrea R. Lim, Cyrus Michael Ghajar · 2021 · Seminars in Cancer Biology
  20. Nitric oxide synthase 2 is involved in the pro-tumorigenic potential of γδ17 T cells in melanoma
    Laëtitia Douguet, Lloyd Bod, Renée Lengagne, Laura Labarthe Démolis, Masashi Kato, Marie‐Françoise Avril, Armelle Prévost‐Blondel · 2016 · OncoImmunology
  21. Pathways of parallel progression
    Cyrus Michael Ghajar, Mina J. Bissell · 2016 · Nature
  22. Melanoma dormancy in a mouse model is linked to GILZ/FOXO3A-dependent quiescence of disseminated stem-like cells
    Yasmine S. Touil, Pascaline Ségard, Pauline Ostyn, Séverine Bégard, Caroline Aspord, Raja El Machhour, Bernadette Masselot, Jérôme Vandomme, Pilar Flamenco, Thierry Idziorek et al. · 2016 · Scientific Reports
  23. Malignant pleural effusion survival prognostication in an Asian population
    Jonathan Caleb Quek, Qiao Li Tan, John Carson Allen, Devanand Anantham · 2020 · Respirology
  24. Antimetastatic defense by CD8+ T cells
    Paulino Tallón de Lara, Héctor Castañón, Michelle Sterpi, Maries F. van den Broek · 2021 · Trends in cancer
  25. MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy
    Irene Romero, Cristina Garrido, Ignacio Algarra, Virginia Chamorro, Antonia Collado, Federico Garrido, Angel Miguel Garcia-Lora · 2018 · Frontiers in Immunology
  26. Metastatic Latency, a Veiled Threat
    Kangsan Kim, Mauricio Marquez-Palencia, Srinivas Malladi · 2019 · Frontiers in Immunology
  27. Epigenetic plasticity in metastatic dormancy: mechanisms and therapeutic implications
    Nathaniel J Robinson, Kimberly A. Parker, William P. Schiemann · 2020 · Annals of Translational Medicine
  28. Beyond the vicious cycle: The role of innate osteoimmunity, automimicry and tumor-inherent changes in dictating bone metastasis
    Katie L. Owen, Belinda S. Parker · 2017 · Molecular Immunology
  29. Where Are We Now and Where Might We Be Headed in Understanding and Managing Brain Metastases in Colorectal Cancer Patients?
    Ribal Bou Mjahed, Christoforos Astaras, Arnaud D. Roth, Thibaud Koessler · 2022 · Current Treatment Options in Oncology
  30. Significance of circulating tumor cells in lung cancer: a narrative review
    Gerhard Hamilton, Barbara Rath, Sandra Stickler · 2023 · Translational Lung Cancer Research
  31. Novel dual-targeting anti-proliferative dihydrotriazine-chalcone derivatives display suppression of cancer cell invasion and inflammation by inhibiting the NF-κB signaling pathway
    Fei-Fei Gan, Ruirui Zhang, Hui-Li Ng, Muthukumar Karuppasamy, Waygene Seah, Wei Hseun Yeap, Siew‐Min Ong, Éva Hadadi, Siew Cheng Wong, Wai‐Keung Chui et al. · 2018 · Food and Chemical Toxicology
  32. The Role of the Innate Immune System in Cancer Dormancy and Relapse
    Noah M. Chernosky, Ilaria Tamagno · 2021 · Cancers
  33. Cell Proliferation in Cutaneous Malignant Melanoma: Relationship with Neoplastic Progression
    Gérald Pierard · 2012 · ISRN Dermatology
  34. Human macrophages survive and adopt activated genotypes in living zebrafish
    Colin D. Paul, Alexus Devine, Kevin S. Bishop, Qing Xu, William J. Wulftange, Hannah Burr, Kathryn M. Daly, Chaunte Lewis, Daniel S. Green, Jack R. Staunton et al. · 2019 · Scientific Reports
  35. Tumor dormancy and the neuroendocrine system: an undisclosed connection?
    Giovanna Zappalà, Paige A. Green, Steve W. Cole · 2012 · Cancer and Metastasis Reviews
  36. Intratumoral antigen signaling traps CD8 + T cells to confine exhaustion to the tumor site
    Munetomo Takahashi, Tsz Y. So, Vitalina Chamberlain-Evans, Robert Hughes, Juan Carlos Yam‐Puc, Katarzyna Kania, Michelle Ruhle, Tiffeney Mann, Martijn J. Schuijs, Paul G. Coupland et al. · 2024 · Science Immunology
  37. Enrichment and detection of bone disseminated tumor cells in models of low tumor burden
    Miranda E. Sowder, Rachelle W. Johnson · 2018 · Scientific Reports
  38. Dormant tumor cells interact with memory CD8+ T cells in RET transgenic mouse melanoma model
    Fernando Flores-Guzmán, Jochen Sven Utikal, Viktor Umansky · 2020 · Cancer Letters
  39. Lessons from Cancer Immunoediting in Cutaneous Melanoma
    Mariana Aris, María Marcela Barrio, José Mordoh · 2012 · Clinical and Developmental Immunology
  40. MET-dependent cancer invasion may be preprogrammed by early alterations of p53-regulated feedforward loop and triggered by stromal cell-derived HGF
    Chang‐Il Hwang, Jinhyang Choi, Zongxiang Zhou, Andrea Flesken‐Nikitin, Alexander Tarakhovsky, Alexander Yu. Nikitin · 2011 · Cell Cycle
  41. COX2 regulation of breast cancer bone metastasis
    John Karavitis, Ming Zhang · 2013 · OncoImmunology
  42. Could Extracellular Vesicles Contribute to Generation or Awakening of “Sleepy” Metastatic Niches?
    Alberto Hernández‐Barranco, Laura Nogués, Héctor Peinado · 2021 · Frontiers in Cell and Developmental Biology
  43. Modulation of Immune Components on Stem Cell and Dormancy in Cancer
    Xiaofan Jiang, Lu Liang, Guanglei Chen, Caigang Liu · 2021 · Cells
  44. The single nucleotide polymorphism g.1548A >G (K469E) of the ICAM-1 gene is associated with worse prognosis in non-small cell lung cancer
    Eirini Thanopoulou, George Kotzamanis, Ioannis S. Pateras, Nicholaos Ziras, Alexandros Papalambros, Theodoros D. Mariolis-Sapsakos, Fragiska Sigala, Elizabeth Johnson, Athanassios Kotsinas, Andreas Scorilas et al. · 2012 · Tumor Biology
  45. T Cells Contribute to Tumor Progression by Favoring Pro-Tumoral Properties of Intra-Tumoral Myeloid Cells in a Mouse Model for Spontaneous Melanoma
    Renée Lengagne, Arnaud Pommier, Jonathan Caron, Laëtitia Douguet, Marylène Garcette, Masashi Kato, Marie‐Françoise Avril, Jean‐Pierre Abastado, Nadège Bercovici, Bruno Lucas et al. · 2011 · PLoS ONE
  46. TH9 cell differentiation, transcriptional control and function in inflammation, autoimmune diseases and cancer
    Yàn Li, Qing Yu, Zhengguo Zhang, Jian Wang, Simin Li, Jiangyuan Zhang, Guangwei Liu · 2016 · Oncotarget
  47. Metabolic landscape of disseminated cancer dormancy
    Stanislav Drápela, Bruna Martins Garcia, Ana P. Gomes, Ana Luísa Correia · 2024 · Trends in cancer
  48. Remodeling the tumor dormancy ecosystem to prevent recurrence and metastasis
    Yu Liang, Wo‐Ming Chen, Youming Zhang, Lei Li · 2026 · Signal Transduction and Targeted Therapy
  49. Tackling cancer cell dormancy: Insights from immune models, and transplantation
    Alexandre Corthay, Tibor Bakács, Govindarajan Thangavelu, Colin C. Anderson · 2021 · Seminars in Cancer Biology
  50. Improving capture efficiency of human cancer cell derived exosomes with nanostructured metal organic framework functionalized beads
    Sareh Zhand, Kun Xiao, Sajad Razavi Bazaz, Ying Zhu, Pritam Bordhan, Dayong Jin, Majid Ebrahimi Warkiani · 2021 · Applied Materials Today
  51. CD26-positive/CD326-negative circulating cancer cells as prognostic markers for colorectal cancer recurrence
    Eva Lieto, Gennaro Galizia, Michele Orditura, Ciro Pasquale Romano, Anna Ginevra Immacolata Zamboli, Paolo Castellano, Andrea Mabilia, ANNAMARIA AURICCHIO, Ferdinando De Vita, Marica Gemei · 2014 · Oncology Letters
  52. Insights into the Regulation of Tumor Dormancy by Angiogenesis in Experimental Tumors
    Stefano Indraccolo · 2012 · Advances in experimental medicine and biology
  53. Disseminated Tumor Cells in the Bone Marrow Negatively Influence Survival after Resection of Colorectal Liver Metastases
    Sebastian Hinz, Jessica Bockhorst, Christian Röder, Jan‐Hendrik Egberts, Clemens Schafmayer, Thomas Küchler, Thomas Becker, Holger Kalthoff · 2012 · Annals of Surgical Oncology
  54. When a House Is Not a Home: A Survey of Antimetastatic Niches and Potential Mechanisms of Disseminated Tumor Cell Suppression
    Sarah B. Crist, Cyrus Michael Ghajar · 2020 · Annual Review of Pathology Mechanisms of Disease
  55. Genetic factors in metastatic progression of cutaneous melanoma: the future role of circulating melanoma cells in prognosis and management
    A. Ireland, Michael Millward, R. Pearce, M. Lee, Mel R. Ziman · 2011 · Clinical & Experimental Metastasis
  56. Experimental models of bone metastasis: Opportunities for the study of cancer dormancy
    Mark Seow Khoon Chong · 2015 · Advanced Drug Delivery Reviews
  57. Emerging Next-Generation Target for Cancer Immunotherapy Research: The Orphan Nuclear Receptor NR2F6
    Victoria Klepsch, Kerstin Siegmund, Gottfried Baier · 2021 · Cancers
  58. The Emerging Interplay Between Recirculating and Tissue-Resident Memory T Cells in Cancer Immunity: Lessons Learned From PD-1/PD-L1 Blockade Therapy and Remaining Gaps
    Silvia Gitto, Ambra Natalini, Fabrizio Antonangeli, Francesca Di Rosa · 2021 · Frontiers in Immunology
  59. Forces at play: exploring factors affecting the cancer metastasis
    Farooq Riaz, Jing Zhang, Fan Pan · 2024 · Frontiers in Immunology
  60. Micrometastatic Dormancy in Uveal Melanoma: A Comprehensive Review of the Evidence, Mechanisms, and Implications for Future Adjuvant Therapies
    Erin E. Nichols, Ann J. Richmond, Anthony B. Daniels · 2016 · International Ophthalmology Clinics
  61. Competition and niche construction in a model of cancer metastasis
    Jimmy J. Qian, Erol Akçay · 2018 · PLoS ONE
  62. Local and distant tumor dormancy during early stage breast cancer are associated with the predominance of infiltrating T effector subsets
    Hussein F. Aqbi, Cara L. Coleman, Melika Zarei, Saeed H. Manjili, Laura Graham, Jennifer E. Koblinski, Chunquing Guo, Yibin Xie, Georgi Guruli, Harry D. Bear et al. · 2020 · Breast Cancer Research
  63. Stem–Mesenchymal Signature Cell Genes Detected in Heterogeneous Circulating Melanoma Cells Correlate With Disease Stage in Melanoma Patients
    Maria Cristina Rapanotti, Elena Campione, Tara Mayte Suarez Viguria, Giulia Spallone, Gaetana Costanza, P Rossi, Augusto Orlandi, Piera Valenti, Sergio Bernardini, Luca Bianchi · 2020 · Frontiers in Molecular Biosciences
  64. The Non-Coding Landscape of Cutaneous Malignant Melanoma: A Possible Route to Efficient Targeted Therapy
    Andreea Daniela Lazăr, Sorina Dinescu, Marieta Costache · 2020 · Cancers
  65. Les étapes précoces du processus métastatique
    Sandra Hubert, Jean‐Pierre Abastado · 2014 · médecine/sciences
  66. Discovering Rare Genes Contributing to Cancer Stemness and Invasive Potential by GBM Single-Cell Transcriptional Analysis
    Lin Pang, Jing Rong Hu, Feng Li, Huating Yuan, Min Yan, Gaoming Liao, Liwen Xu, Bo Pang, Yanyan Ping, Yun Xiao et al. · 2019 · Cancers
  67. The Entanglement between Mitochondrial DNA and Tumor Metastasis
    Qiwei Wu, Hsiang‐i Tsai, Haitao Zhu, Dongqing Wang · 2022 · Cancers
  68. RETRACTED: Dendritic cell-derived exosomes (Dex): Underlying the role of exosomes derived from diverse DC subtypes in cancer pathogenesis
    Gulixian Tuluwengjiang, Irodakhon Rasulova, Shamim Ahmed, Bahman Abedi Kiasari, Ioan Sârbu, Carmen Iulia Ciongradi, Thabit Moath Omar, Farah Hussain, Mahmood Jasem Jawad, Roxana Yolanda Castillo-Acobo et al. · 2024 · Pathology - Research and Practice · Retracted
  69. Metastatic organotropism: a brief overview
    Margarida Carrolo, João A. I. Miranda, Guilherme Vilhais, António Quintela, Mário Fontes e Sousa, Diogo Alpuim Costa, Francisco Rodrigues Pinto · 2024 · Frontiers in Oncology
  70. Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells
    Claudia Maenz, Eva Lenfert, Klaus Pantel, Udo Schumacher, Wolfgang Deppert, Florian Wegwitz · 2015 · BMC Cancer
  71. Mouse Models of Metastasis and Dormancy
    Ahmed Mahmoud, Karuna Ganesh · 2023 · Cold Spring Harbor Perspectives in Medicine
  72. Animal models of uveal melanoma
    Ogul Ersin Uner, Nikhila Gandrakota, Corrina P. Azarcon, Hans E. Grossniklaus · 2021 · Annals of Eye Science
  73. Pharmacologic Inhibition of EIF4A Blocks NRF2 Synthesis to Prevent Osteosarcoma Metastasis
    Michael M. Lizardo, Christopher S. Hughes, Yue Z. Huang, Taras Shyp, Alberto Delaidelli, Hai‐Feng Zhang, Sol Snir Shaool, Annalena F. Renner, Farez Burwag, Leanne C. Sayles et al. · 2024 · Clinical Cancer Research
  74. Outcome of soft-tissue sarcoma patients who were alive and event-free more than five years after initial treatment
    Tomoki Nakamura, Robert John Grimer, S. R. Carter, Roger M. Tillman, A. Abudu, Lee Marcus Jeys, Akihiro Sudo · 2013 · The Bone & Joint Journal
  75. The natural defense system and the normative self model
    Philippe Kourilsky · 2016 · F1000Research
  76. Immunological network signatures of cancer progression and survival
    Trevor Clancy, Marco Pedicini, Filippo Castiglione, Daniele Santoni, Vegard Nygaard, Timothy J. Lavelle, Mikael Benson, Eivind J. Hovig · 2011 · BMC Medical Genomics
  77. FISHtrees 3.0: Tumor Phylogenetics Using a Ploidy Probe
    Edward Michael Gertz, Salim Akhter Chowdhury, Woei-Jyh Lee, Darawalee Wangsa, Kerstin Heselmeyer‐Haddad, Thomas Ried, Russell S. Schwartz, Alejandro A. Schäffer · 2016 · PLoS ONE
  78. Metastasis and the evolution of dispersal
    Tazzio Tissot, François Massol, Beáta Újvári, Catherine Alix‐Panabières, Nicolas Loeuille, Frédéric Thomas A · 2019 · Proceedings of the Royal Society B Biological Sciences
  79. Pathology of circulating tumor cells and the available capture tools (Review)
    Yibing Guan, Fangshi Xu, Juanhua Tian, Hongwei Chen, Chuance Yang, Shanlong Huang, Ke Gao, Ziyan Wan, Mingrui Li, Minxin He et al. · 2020 · Oncology Reports
  80. Metastatic Heterogeneity of Breast Cancer: Companion and Theranostic Approach in Nuclear Medicine
    Christopher Montemagno, Gilles Pagès · 2020 · Cancers
  81. Microenvironmental modulation of the developing tumour: an immune‐stromal dialogue
    James O. Jones, William M. Moody, Jacqueline D. Shields · 2020 · Molecular Oncology
  82. Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2
    Guanwen Wang, Juan Wang, Antao Chang, Dongmei Cheng, SHAN HU HUANG, Dan Wu, Sherona R. Sirkisoon, Shuang Yang, Hui‐Kuan Lin, Hui‐Wen Lo et al. · 2020 · Oncogene
  83. T-Cell Mediated Immune Responses Induced in ret Transgenic Mouse Model of Malignant Melanoma
    Oliver Abschütz, Wolfram Osen, Kathrin Frank, Masashi Kato, Dirk Schadendorf, Viktor Umansky · 2012 · Cancers
  84. Stimuli-responsive chitosan based nanoparticles in cancer therapy and diagnosis: A review
    Guotao Fang, Hao Peng, Ruonan Qiao, Bixia Liu, Xiujuan Shi, Zhenfei Wang, Peng Sun · 2024 · International Journal of Biological Macromolecules
  85. Rapid in vivo validation of candidate drivers derived from the PTEN-mutant prostate metastasis genome
    Hyejin Cho, Tali M. Herzka, Carlos E. Stahlhut, Kaitlin E. Watrud, Brian D. Robinson, Lloyd C. Trotman · 2015 · Methods
  86. Could targeting bone delay cancer progression? Potential mechanisms of action of bisphosphonates
    Rebecca Aft, Jose-Ricardo Perez, Noopur S Raje, Vera Hirsh, Fred Saad C · 2011 · Critical Reviews in Oncology/Hematology
  87. Her2 promotes early dissemination of breast cancer by suppressing the p38-MK2-Hsp27 pathway that is targetable by Wip1 inhibition
    Juan Wang, Guanwen Wang, Dongmei Cheng, SHAN HU HUANG, Antao Chang, Xiaoming Tan, Qiong Wang, Shaorong Zhao, Dan Wu, Andy T. Liu et al. · 2020 · Oncogene
  88. Circulating Tumor Cells: A Window to Understand Cancer Metastasis, Monitor and Fight Against Cancers
    Lei Xu, Jonathan Shamash, Yong‐Jie Lu · 2015 · Journal of cancer research updates
  89. T cells in tumor microenvironment
    Yağmur Kiraz, Yusuf Baran, Ayten Nalbant · 2015 · Tumor Biology
  90. NLGP Attenuates Murine Melanoma and Carcinoma Metastasis by Modulating Cytotoxic CD8+ T Cells
    Avishek Bhuniya, Ipsita Guha, Nilanjan Ganguly, Akata Saha, Shayani Dasgupta, Partha Sarathi Nandi, Arnab Das, Sarbari Ghosh, Tithi Ghosh, Enamul Haque et al. · 2020 · Frontiers in Oncology
  91. The Genetic Basis of Dormancy and Awakening in Cutaneous Metastatic Melanoma
    Agata Janowska, Michela Iannone, Cristian Fidanzi, Marco Romanelli, Luca Filippi, Marzia Del Re, Manuella Martins, Valentina Dini · 2022 · Cancers
  92. Host-Related Factors in the Interplay among Inflammation, Immunity and Dormancy in Breast Cancer Recurrence and Prognosis: An Overview for Clinicians
    Lorenzo Ruggieri, Anna Moretti, Rossana Berardi, Maria Silvia Cona, Davide Dalu, Cecilia Villa, Davide Chizzoniti, Sheila Piva, Anna Gambaro, Nicla Maria La Verde · 2023 · International Journal of Molecular Sciences
  93. Dormancy of cutaneous melanoma
    Kathrin Singvogel, Birgit Schittek · 2024 · Cancer Cell International
  94. HPK1 Dysregulation‐Associated NK Cell Dysfunction and Defective Expansion Promotes Metastatic Melanoma Progression
    Woo Seon Choi, Hyung‐Joon Kwon, Eunbi Yi, Haeun Lee, Jung Min Kim, Hyo Jin Park, Eun Ji Choi, Myoung Eun Choi, Young Hoon Sung, Chong Hyun Won et al. · 2024 · Advanced Science
  95. Changing T-cell enigma: Cancer killing or cancer control?
    Thomas Wieder, Heidi Braumüller, Ellen Brenner, Lars Zender, Martin Röcken · 2013 · Cell Cycle
  96. Cancer Immunoediting
    Michele W.L. Teng, Michael H. Kershaw, Mark John Smyth · 2013 · Elsevier eBooks
  97. Endobronchial melanoma metastasis 40 years after the excision of the primary cutaneous tumor
    Georgia Karpathiou, Μarios E. Froudarakis, Vanessa Da Cruz, Fabien Forest, Maxime Sauvage, Jean Michel Vergnon, Michel Péoc’h · 2017 · Medicine
  98. The Results of Stricter Inclusion Criteria in an Immunomagnetic Detection Study of Micrometastatic Cells in Bone Marrow of Uveal Melanoma Patients - Relevance for Dormancy
    Nils Andreas Eide, Ragnar S. Faye, Hanne K. Høifødt, Leiv Sandvik, Geir A. Qvale, Rowan Thomas Faber, Peter Jebsen, Gunnar Kvalheim, Øystein Fodstad · 2017 · Pathology & Oncology Research
  99. In Vivo Screening of S100B Inhibitors for Melanoma Therapy
    Danna B. Zimmer, Rena G. Lapidus, David J. Weber · 2012 · Methods in molecular biology
  100. Myeloid cells
    Benjamin Toh, Benjamin Toh, Jean‐Pierre Abastado, Jean‐Pierre Abastado · 2012 · OncoImmunology